List view / Grid view
6 December 2010 | By Novartis
with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)...
17 November 2010 | By Novartis
Novartis presented a strategic overview of the company's diversified healthcare portfolio which creates potential for future sustainable growth...
19 August 2010 | By Gül Erdemli & Dmitri Mikhailov, Center for Proteomic Chemistry, Novartis Institutes for BioMedical Sciences and Albert M Kim, Translational Medicine, Novartis Institutes for BioMedical Sciences
The preclinical assessment of a small molecule’s liability for QT interval prolongation is an essential part of the drug discovery process. Patch clamp assays for heterologously expressed recombinant cardiac ion channels are widely used in the pharmaceutical industry to evaluate potential drug-channel interactions. These assays are generally acute assessments and…
21 July 2010 | By NG Online News
Back in May, it was announced that new stem cell research would reduce the need for animal testing...
2 July 2010 | By NG Online News
The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer...
17 June 2010 | By CCA on behalf of Novartis
Data presented at the ECFS Conference in Valencia demonstrate that TIPTM* is as effective as the current standard of care...
18 May 2010 | By
New analyses of data pooled from the indacaterol Phase III program that led to approval in the EU...
21 September 2007 | By Paul J Groot-Kormelink PhD, Pamela R Tranter PhD and Martin Gosling PhD, Novartis
The widespread expression of ion channels and their ability to significantly modulate cell function makes them attractive drug targets1. Therapeutic agents which target ion channel proteins comprise the third best selling class of prescription drugs with US sales in 2002 estimated at $12 billion. Somewhat surprisingly the discovery of many…
European Pharmaceutical Review brings you a comprehensive guide to the current developments and possible future innovations within Process Analytical Technologies...
